In HNC, amplification of CORTACTIN gene has been linked to poor clinical outcome mainly in patients with laryngeal carcinoma (Gibcus et al., 2008; Rodrigo et al., 2009). This evidence concerns the gene CTTN and laryngeal carcinoma.